Findings

What do systematic reviews say?

4 questions · 6 findings · 1 reviews · ENT

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 6 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Improvement in vertigo frequency · Ménière’s disease

It is very uncertain whether betahistine changes improvement in vertigo frequency compared with placebo/no treatment (very low certainty).

2 findings from 1 review

Systemic pharmacological interventions for Ménière’s disease 2023 · Cochrane Headline outcomes only
RR 1.5 [0.98, 2.29]
1 study · 70 participants
Very low
Systemic pharmacological interventions for Ménière’s disease 2023 · Cochrane Headline outcomes only
RR 1.11 [0.93, 1.32]
1 study · 62 participants
Very low

Vertigo (global score) at < 3 months · Ménière’s disease

1 finding from 1 review

Systemic pharmacological interventions for Ménière’s disease 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Very low

Change in vertigo frequency · Ménière’s disease

2 findings from 1 review

Systemic pharmacological interventions for Ménière’s disease 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 117 participants
Very low
Systemic pharmacological interventions for Ménière’s disease 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 214 participants
Very low

Serious adverse events · Ménière’s disease

It is very uncertain whether betahistine changes serious adverse events compared with placebo/no treatment (very low certainty).

1 finding from 1 review

Systemic pharmacological interventions for Ménière’s disease 2023 · Cochrane Headline outcomes only
RR 1.2 [0.63, 2.29]
1 study · 220 participants
Very low